Dr. Reddy's Laboratories

Dr. Reddy's Laboratories

Pharmaceuticals
Dr. Reddy’s is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly half of its generics sales, and it services India (about 20% of its generics sales), Russia (10%), and certain European and Latin American countries. Beyond simple generics, Dr. Reddy’s also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy’s has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy’s also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.

$12.3B

Market Cap • 11/17/2026

1984

(42 years)

Founded

2001

(25 years ago)

IPO

NYSE

Listing Exchange

Flag of India

India

Country

Valuation

P/B

3,1

P/S

3,5

P/EBITDA

21,8

P/OCF

39,4

P/FCF

89,1

P/E

69,7

BVPS

4,8

EPS

0,2

Market Cap

Market Cap

12,3B

EV

12,3B

EV/Revenue

3,5

EV/EBITDA

21,8

EV/EBIT

35,7

Payout

Dividend Per Share

0

Dividend Yield

0,3%

Buyback Yield

0%

Total Yield

0,3%

Dividend Yield 5Y

0,5%

Payout

23,5%

Retained Earnings

3,8B

Profitability

Gross Margin

49,5%

EBITDA Margin

16%

EBIT Margin

9,8%

Net Margin

8,4%

D&A/EBITDA

0%

R&D/Revenue

6,9%

Capex/Revenue

4,9%

Capex/D&A

78,9%

Capex/OCF

55,7%

SBC/OCF

1%

% PPE

20%

% Goodwill

2,3%

ROE

7,8%

ROIC

6,8%

Growth

CAGR Revenue 5Y

0,7%

CAGR Op. Income 5Y

-18,1%

CAGR Net Income 5Y

-3,8%

CAGR EPS 5Y

-7,7%

CAGR OCF 5Y

5,7%

Leverage

N.D./EBITDA

—

Debt/Equity

0%

Current Ratio

1,9

Quick Ratio

1,1

Interest Coverage

717,2%

Premium

Unlock 100% of the data and have immediate access on more than 6.000 companies with updated information!
  • Unrestricted access
  • Unlimited data history
  • Analysis videos
  • Quarterly highlights
  • Customizable financials table
  • Ranking
  • Discussions

...and much more!

Get Premium